These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30122504)

  • 1. Definitions of Stage D heart failure and outcomes among outpatients with heart failure and reduced ejection fraction.
    Hedley JS; Samman-Tahhan A; McCue AA; Bjork JB; Butler J; Georgiopoulou VV; Morris AA; Kalogeropoulos AP
    Int J Cardiol; 2018 Dec; 272():250-254. PubMed ID: 30122504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. INTERMACS Profiles and Outcomes Among Non-Inotrope-Dependent Outpatients With Heart Failure and Reduced Ejection Fraction.
    Samman-Tahhan A; Hedley JS; McCue AA; Bjork JB; Georgiopoulou VV; Morris AA; Butler J; Kalogeropoulos AP
    JACC Heart Fail; 2018 Sep; 6(9):743-753. PubMed ID: 30098970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support) Profiling Identifies Ambulatory Patients at High Risk on Medical Therapy After Hospitalizations for Heart Failure.
    Stewart GC; Kittleson MM; Patel PC; Cowger JA; Patel CB; Mountis MM; Johnson FL; Guglin ME; Rame JE; Teuteberg JJ; Stevenson LW
    Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 27834198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of the updated 2018 HFA-ESC definition of advanced heart failure: results from the HELP-HF registry.
    Pagnesi M; Lombardi CM; Chiarito M; Stolfo D; Baldetti L; Loiacono F; Tedino C; Arrigoni L; Ghiraldin D; Tomasoni D; Inciardi RM; Maccallini M; Villaschi A; Gasparini G; Montella M; Contessi S; Cocianni D; Perotto M; Barone G; Merlo M; Cappelletti AM; Sinagra G; Pini D; Metra M
    Eur J Heart Fail; 2022 Sep; 24(9):1493-1503. PubMed ID: 35603658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression to Stage D Heart Failure Among Outpatients With Stage C Heart Failure and Reduced Ejection Fraction.
    Kalogeropoulos AP; Samman-Tahhan A; Hedley JS; McCue AA; Bjork JB; Markham DW; Bhatt KN; Georgiopoulou VV; Smith AL; Butler J
    JACC Heart Fail; 2017 Jul; 5(7):528-537. PubMed ID: 28624484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).
    Carson PE; Anand IS; Win S; Rector T; Haass M; Lopez-Sendon J; Miller A; Teerlink JR; White M; McKelvie RS; Komajda M; Zile MR; McMurray JJ; Massie B
    JACC Heart Fail; 2015 Jun; 3(6):429-441. PubMed ID: 25982110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.
    Lupón J; Díez-López C; de Antonio M; Domingo M; Zamora E; Moliner P; González B; Santesmases J; Troya MI; Bayés-Genís A
    Eur J Heart Fail; 2017 Dec; 19(12):1615-1623. PubMed ID: 28387002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. INTERMACS profiles and outcomes of ambulatory advanced heart failure patients: A report from the REVIVAL Registry.
    Kittleson MM; Shah P; Lala A; McLean RC; Pamboukian S; Horstmanshof DA; Thibodeau J; Shah K; Teuteberg J; Gilotra NA; Taddei-Peters WC; Cascino TM; Richards B; Khalatbari S; Jeffries N; Stevenson LW; Mann D; Aaronson KD; Stewart GC;
    J Heart Lung Transplant; 2020 Jan; 39(1):16-26. PubMed ID: 31522912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial Changes in Left Ventricular Ejection Fraction and Outcomes in Outpatients With Heart Failure and Preserved Ejection Fraction.
    Kalogeropoulos AP; Kim S; Rawal S; Jadonath A; Tangutoori R; Georgiopoulou V
    Am J Cardiol; 2019 Sep; 124(5):729-735. PubMed ID: 31272702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial.
    Anand IS; Rector TS; Cleland JG; Kuskowski M; McKelvie RS; Persson H; McMurray JJ; Zile MR; Komajda M; Massie BM; Carson PE
    Circ Heart Fail; 2011 Sep; 4(5):569-77. PubMed ID: 21715583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicians' guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry.
    Komajda M; Cowie MR; Tavazzi L; Ponikowski P; Anker SD; Filippatos GS;
    Eur J Heart Fail; 2017 Nov; 19(11):1414-1423. PubMed ID: 28463464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of heart failure with preserved ejection fraction in a Southeast Asian cohort.
    Hoong CW; Lim CP; Gao F; Chen Q; Kawa LB; Ching CK; Sim DK
    J Cardiovasc Med (Hagerstown); 2015 Sep; 16(9):583-90. PubMed ID: 25022929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frailty Assessment in Advanced Heart Failure.
    Madan SA; Fida N; Barman P; Sims D; Shin J; Verghese J; Piña I; Jorde U; Patel SR
    J Card Fail; 2016 Oct; 22(10):840-4. PubMed ID: 26883168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF]).
    Cherian TS; Shrader P; Fonarow GC; Allen LA; Piccini JP; Peterson ED; Thomas L; Kowey PR; Gersh BJ; Mahaffey KW
    Am J Cardiol; 2017 Jun; 119(11):1763-1769. PubMed ID: 28416199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and outcomes of young and very young adults with heart failure: The CHARM programme (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity).
    Wong CM; Hawkins NM; Jhund PS; MacDonald MR; Solomon SD; Granger CB; Yusuf S; Pfeffer MA; Swedberg K; Petrie MC; McMurray JJ
    J Am Coll Cardiol; 2013 Nov; 62(20):1845-54. PubMed ID: 23850914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of hyponatremia among ambulatory patients with heart failure and preserved and reduced ejection fractions.
    Bavishi C; Ather S; Bambhroliya A; Jneid H; Virani SS; Bozkurt B; Deswal A
    Am J Cardiol; 2014 Jun; 113(11):1834-8. PubMed ID: 24837261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Diabetes and 1-Year Adverse Clinical Outcomes in a Multinational Cohort of Ambulatory Patients With Chronic Heart Failure: Results From the ESC-HFA Heart Failure Long-Term Registry.
    Dauriz M; Targher G; Laroche C; Temporelli PL; Ferrari R; Anker S; Coats A; Filippatos G; Crespo-Leiro M; Mebazaa A; Piepoli MF; Maggioni AP; Tavazzi L;
    Diabetes Care; 2017 May; 40(5):671-678. PubMed ID: 28255009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced Heart Failure Characteristics and Outcomes in Women and Men.
    Farooqui N; Killian JM; Smith J; Redfield MM; Dunlay SM
    J Am Heart Assoc; 2024 Jul; 13(13):e033374. PubMed ID: 38904243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multistate Model to Predict Heart Failure Hospitalizations and All-Cause Mortality in Outpatients With Heart Failure With Reduced Ejection Fraction: Model Derivation and External Validation.
    Upshaw JN; Konstam MA; Klaveren Dv; Noubary F; Huggins GS; Kent DM
    Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27514751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive population-based characterization of heart failure with mid-range ejection fraction.
    Koh AS; Tay WT; Teng THK; Vedin O; Benson L; Dahlstrom U; Savarese G; Lam CSP; Lund LH
    Eur J Heart Fail; 2017 Dec; 19(12):1624-1634. PubMed ID: 28948683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.